A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial)

Authors

Keywords

Journal

Volume 89, Issue 4, Pages 330-338

Publisher

BMJ

Online

2017-12-17

DOI

10.1136/jnnp-2017-317101

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started